# Radiant Biotherapeutics Inc. — Form D

Radiant Biotherapeutics Inc. of Montreal QC, Z4, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-01. The offering totals $34.3M, of which $34.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-10-01
- Form: D
- Accession: 0002038848-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $34.3M
- Amount sold: $34.3M
- Minimum investment: $500K
- Investors: 7
- Date of first sale: 2024-08-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-525543

## Issuer

- Name: Radiant Biotherapeutics Inc.
- CIK: 0002038848
- Entity type: Corporation
- Jurisdiction: QUEBEC, CANADA
- Incorporated: 2020
- Address: 3, Place Ville-Marie, Montreal QC, Z4, H2B 0E7
- Phone: 514-298-4222

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Arthur Fratamico | Executive Officer | Montreal QC, Z4 |
| Arthur Fratamico | Promoter | Montreal QC, Z4 |

## More

- [CIK 2038848 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2038848&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002038848-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.